Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Molecular profiling reveals low- and high-grade forms of primary melanoma.

Harbst K, Staaf J, Lauss M, Karlsson A, Måsbäck A, Johansson I, Bendahl PO, Vallon-Christersson J, Törngren T, Ekedahl H, Geisler J, Höglund M, Ringnér M, Lundgren L, Jirström K, Olsson H, Ingvar C, Borg Å, Tsao H, Jönsson G.

Clin Cancer Res. 2012 Aug 1;18(15):4026-36. doi: 10.1158/1078-0432.CCR-12-0343. Epub 2012 Jun 6. Erratum in: Clin Cancer Res. 2012 Oct 15;18(20):5829. Höglund, Markus [corrected to Höglund, Mattias]; Ringnér, Mattias [corrected to Ringnér, Markus].

2.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

3.

A nine-gene signature predicting clinical outcome in cutaneous melanoma.

Brunner G, Reitz M, Heinecke A, Lippold A, Berking C, Suter L, Atzpodien J.

J Cancer Res Clin Oncol. 2013 Feb;139(2):249-58. doi: 10.1007/s00432-012-1322-z. Epub 2012 Oct 9.

PMID:
23052696
4.

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.

Jönsson G, Busch C, Knappskog S, Geisler J, Miletic H, Ringnér M, Lillehaug JR, Borg A, Lønning PE.

Clin Cancer Res. 2010 Jul 1;16(13):3356-67. doi: 10.1158/1078-0432.CCR-09-2509. Epub 2010 May 11.

5.

Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.

Onken MD, Worley LA, Ehlers JP, Harbour JW.

Cancer Res. 2004 Oct 15;64(20):7205-9.

6.

Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.

Nsengimana J, Laye J, Filia A, Walker C, Jewell R, Van den Oord JJ, Wolter P, Patel P, Sucker A, Schadendorf D, Jönsson GB, Bishop DT, Newton-Bishop J.

Oncotarget. 2015 May 10;6(13):11683-93.

7.

Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues.

Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M.

Clin Cancer Res. 2007 Feb 1;13(3):806-15.

8.

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma.

Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, Gonzalez R, Lyle S, Johnson CE, Oelschlager KM, Jackson GL, Greisinger AJ, Maetzold D, Delman KA, Lawson DH, Stone JF.

Clin Cancer Res. 2015 Jan 1;21(1):175-83. doi: 10.1158/1078-0432.CCR-13-3316.

9.

CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.

Thies A, Moll I, Berger J, Wagener C, Brümmer J, Schulze HJ, Brunner G, Schumacher U.

J Clin Oncol. 2002 May 15;20(10):2530-6.

PMID:
12011132
10.

Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.

Kannengiesser C, Spatz A, Michiels S, Eychène A, Dessen P, Lazar V, Winnepenninckx V, Lesueur F, Druillennec S, Robert C, van den Oord JJ, Sarasin A, Bressac-de Paillerets B; EORTC Melanoma group.

Mol Oncol. 2008 Apr;1(4):425-30. doi: 10.1016/j.molonc.2008.01.002. Epub 2008 Jan 12.

11.

Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.

Kitago M, Martinez SR, Nakamura T, Sim MS, Hoon DS.

Clin Cancer Res. 2009 May 1;15(9):2988-94. doi: 10.1158/1078-0432.CCR-08-3172. Epub 2009 Mar 31.

12.

cDNA-array profiling of melanomas and paired melanocyte cultures.

Mischiati C, Natali PG, Sereni A, Sibilio L, Giorda E, Cappellacci S, Nicotra MR, Mariani G, Di Filippo F, Catricalà C, Gambari R, Grammatico P, Giacomini P.

J Cell Physiol. 2006 Jun;207(3):697-705.

PMID:
16523488
13.

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling.

Worley LA, Long MD, Onken MD, Harbour JW.

Melanoma Res. 2008 Jun;18(3):184-90. doi: 10.1097/CMR.0b013e3282feeac6.

PMID:
18477892
14.

Prognostic significance of cytoplasmic p27 expression in human melanoma.

Chen G, Cheng Y, Zhang Z, Martinka M, Li G.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2212-21. doi: 10.1158/1055-9965.EPI-11-0472. Epub 2011 Aug 9.

15.

Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.

Murali R, Haydu LE, Long GV, Quinn MJ, Saw RP, Shannon K, Spillane AJ, Stretch JR, Kefford RF, Thompson JF, Scolyer RA.

Ann Surg Oncol. 2012 Jun;19(6):1782-9. doi: 10.1245/s10434-012-2265-y. Epub 2012 Feb 14.

PMID:
22350600
16.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M.

J Clin Oncol. 2013 Nov 20;31(33):4252-9. doi: 10.1200/JCO.2013.51.3002. Epub 2013 Oct 14.

17.

Cytoplasmic Skp2 expression is increased in human melanoma and correlated with patient survival.

Chen G, Cheng Y, Zhang Z, Martinka M, Li G.

PLoS One. 2011 Feb 28;6(2):e17578. doi: 10.1371/journal.pone.0017578.

18.

Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.

Koh SS, Wei JP, Li X, Huang RR, Doan NB, Scolyer RA, Cochran AJ, Binder SW.

Mod Pathol. 2012 Jun;25(6):828-37. doi: 10.1038/modpathol.2012.32. Epub 2012 Mar 9.

19.

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.

Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S.

PLoS One. 2012;7(1):e29989. doi: 10.1371/journal.pone.0029989. Epub 2012 Jan 13.

20.

Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.

Lange CA, Tisch-Rottensteiner J, Böhringer D, Martin G, Schwartzkopff J, Auw-Haedrich C.

Ophthalmology. 2012 Sep;119(9):1924-9. doi: 10.1016/j.ophtha.2012.03.037. Epub 2012 Jun 1.

PMID:
22658715
Items per page

Supplemental Content

Write to the Help Desk